General Information of Drug Off-Target (DOT) (ID: OTAQGWYA)

DOT Name Plasmalemma vesicle-associated protein (PLVAP)
Synonyms Fenestrated endothelial-linked structure protein; Plasmalemma vesicle protein 1; PV-1
Gene Name PLVAP
Related Disease
Hepatocellular carcinoma ( )
Adult T-cell leukemia/lymphoma ( )
Advanced cancer ( )
Brain neoplasm ( )
Breast cancer ( )
Diabetic macular edema ( )
Diabetic retinopathy ( )
Diarrhea 10, protein-losing enteropathy type ( )
Protein-losing enteropathy ( )
Retinopathy ( )
Congenital diarrhea 7 with exudative enteropathy ( )
Kaposi sarcoma ( )
UniProt ID
PLVAP_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF06637
Sequence
MGLAMEHGGSYARAGGSSRGCWYYLRYFFLFVSLIQFLIILGLVLFMVYGNVHVSTESNL
QATERRAEGLYSQLLGLTASQSNLTKELNFTTRAKDAIMQMWLNARRDLDRINASFRQCQ
GDRVIYTNNQRYMAAIILSEKQCRDQFKDMNKSCDALLFMLNQKVKTLEVEIAKEKTICT
KDKESVLLNKRVAEEQLVECVKTRELQHQERQLAKEQLQKVQALCLPLDKDKFEMDLRNL
WRDSIIPRSLDNLGYNLYHPLGSELASIRRACDHMPSLMSSKVEELARSLRADIERVARE
NSDLQRQKLEAQQGLRASQEAKQKVEKEAQAREAKLQAECSRQTQLALEEKAVLRKERDN
LAKELEEKKREAEQLRMELAIRNSALDTCIKTKSQPMMPVSRPMGPVPNPQPIDPASLEE
FKRKILESQRPPAGIPVAPSSG
Function
Endothelial cell-specific membrane protein involved in the formation of the diaphragms that bridge endothelial fenestrae. It is also required for the formation of stomata of caveolae and transendothelial channels. Functions in microvascular permeability, endothelial fenestrae contributing to the passage of water and solutes and regulating transcellular versus paracellular flow in different organs. Plays a specific role in embryonic development.
Tissue Specificity Expressed in lung, kidney, heart, aorta, placenta, muscle, pituitary gland, adrenals, mammary gland, bladder, lymph node, bone marrow, trachea, digestive tract, liver and tumor-associated endothelium.

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Hepatocellular carcinoma DIS0J828 Definitive Biomarker [1]
Adult T-cell leukemia/lymphoma DIS882XU Strong Altered Expression [2]
Advanced cancer DISAT1Z9 Strong Altered Expression [3]
Brain neoplasm DISY3EKS Strong Biomarker [4]
Breast cancer DIS7DPX1 Strong Genetic Variation [5]
Diabetic macular edema DIS162FN Strong Biomarker [6]
Diabetic retinopathy DISHGUJM Strong Altered Expression [3]
Diarrhea 10, protein-losing enteropathy type DISXHSNJ Strong Autosomal recessive [7]
Protein-losing enteropathy DISM3WQO Strong Genetic Variation [8]
Retinopathy DISB4B0F Strong Altered Expression [6]
Congenital diarrhea 7 with exudative enteropathy DISNANDK Supportive Autosomal recessive [8]
Kaposi sarcoma DISC1H1Z Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Plasmalemma vesicle-associated protein (PLVAP). [10]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Plasmalemma vesicle-associated protein (PLVAP). [14]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Plasmalemma vesicle-associated protein (PLVAP). [15]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Plasmalemma vesicle-associated protein (PLVAP). [11]
Selenium DM25CGV Approved Selenium increases the expression of Plasmalemma vesicle-associated protein (PLVAP). [12]
Malathion DMXZ84M Approved Malathion decreases the expression of Plasmalemma vesicle-associated protein (PLVAP). [13]
------------------------------------------------------------------------------------

References

1 Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells initro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology. 2017 Jun;152(8):2022-2036.
2 Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen.Int J Cancer. 1991 Jun 19;48(4):623-30. doi: 10.1002/ijc.2910480423.
3 The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.Fluids Barriers CNS. 2018 Sep 20;15(1):24. doi: 10.1186/s12987-018-0109-2.
4 Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.Clin Cancer Res. 2005 Nov 1;11(21):7643-50. doi: 10.1158/1078-0432.CCR-05-1099.
5 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.Nat Genet. 2010 Oct;42(10):885-92. doi: 10.1038/ng.669. Epub 2010 Sep 19.
6 An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys.Eur J Pharmacol. 2019 Jul 5;854:240-246. doi: 10.1016/j.ejphar.2019.04.035. Epub 2019 Apr 23.
7 Establishing the role of PLVAP in protein-losing enteropathy: a homozygous missense variant leads to an attenuated phenotype. J Med Genet. 2018 Nov;55(11):779-784. doi: 10.1136/jmedgenet-2018-105299. Epub 2018 Jun 6.
8 Mutations in plasmalemma vesicle-associated protein cause severe syndromic protein-losing enteropathy. J Med Genet. 2018 Sep;55(9):637-640. doi: 10.1136/jmedgenet-2018-105262. Epub 2018 Apr 16.
9 Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Szary syndrome and Kaposi's sarcoma.Cancer Res. 1992 Aug 15;52(16):4391-5.
10 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
11 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
12 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
13 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.